NASDAQ : BLLN
BillionToOne, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 113.32 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.35B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.35B |
| Enterprise Value | 4.94B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 42.64M |
| Shares Outstanding | 47.19M |
| Shares Change (YoY) | +319.03% |
| Shares Change (QoQ) | +2.69% |
| Owned by Insiders (%) | 10.56% |
| Owned by Institutions (%) | 35.91% |
| Float | 36.71M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 147.36 |
| Forward PE | 154.91 |
| PS Ratio | 13.46 |
| Forward PS | 10.52 |
| PB Ratio | 9.89 |
| P/TBV Ratio | 9.96 |
| P/FCF Ratio | 161.19 |
| P/OCF Ratio | 117.90 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 148.97 |
| EV / Sales | 12.44 |
| EV / EBITDA | 98.38 |
| EV / EBIT | 114.14 |
| EV / FCF | 148.99 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 11.69 |
| Quick Ratio | 11.19 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 2.25 |
| Debt / FCF | 4.34 |
| Interest Coverage | 1,056.15 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 10.68% |
| Return on Assets (ROA) | 5.19% |
| Return on Invested Capital (ROIC) | 35.25% |
| Return on Capital Employed (ROCE) | 6.42% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $557,380 |
| Profits Per Employee | $46,532 |
| Employee Count | 713 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 6.55 |
Taxes
| Measure | Value |
|---|
| Income Tax | 194,000 |
| Effective Tax Rate | 0.51% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 103.81 |
| 200-Day Moving Average | 96.44 |
| Relative Strength Index (RSI) | 59.48 |
| Average Volume (20 Days) | 495,600 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.93M |
| Short Previous Month | 2.82M |
| Short % of Shares Out | 6.21% |
| Short % of Float | 7.99% |
| Short Ratio (days to cover) | 4.68 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 397.41M |
| Gross Profit | 283.22M |
| Operating Income | 43.30M |
| Pretax Income | 37.91M |
| Net Income | 33.18M |
| EBITDA | 50.24M |
| EBIT | 43.30M |
| Earnings Per Share (EPS) | $0.77 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 548.63M |
| Total Debt | 143.92M |
| Net Cash | 404.71M |
| Net Cash Per Share | $8.58 |
| Equity (Book Value) | 536.81M |
| Book Value Per Share | 11.46 |
| Working Capital | 595.65M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 45.35M |
| Capital Expenditures | -12.18M |
| Depreciation & Amortization | 6.94M |
| Net Borrowing | 28.98M |
| Free Cash Flow | 33.17M |
| FCF Per Share | $0.70 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.27% |
| Operating Margin | 10.90% |
| Pretax Margin | 9.54% |
| Profit Margin | 8.35% |
| EBITDA Margin | 12.64% |
| EBIT Margin | 10.90% |
| FCF Margin | 8.35% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -319.03% |
| Shareholder Yield | -319.03% |
| Earnings Yield | 0.68% |
| FCF Yield | 0.62% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $129.00 |
| Price Target Difference | 13.84% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 33.74% |
| EPS Growth Forecast (3Y) | 63.65% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 14.08 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |